PERSPECTA

News from every angle

Back to headlines

Analysis: Why 'Big Pharma' May Avoid Developing Cheap Anti-Aging Drugs

An analysis explores why major pharmaceutical companies are unlikely to develop affordable anti-aging drugs, despite scientific hypotheses suggesting generic drugs like metformin and rapamycin could slow aging.

17 Jul, 10:30 — 17 Jul, 10:30
PostShare